Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) EBITDA (2016 - 2025)

Historic EBITDA for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to -$51.8 million.

  • Bruker's EBITDA fell 17606.46% to -$51.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.0 million, marking a year-over-year decrease of 7750.44%. This contributed to the annual value of $253.1 million for FY2024, which is 4206.91% down from last year.
  • Bruker's EBITDA amounted to -$51.8 million in Q3 2025, which was down 17606.46% from $11.9 million recorded in Q2 2025.
  • In the past 5 years, Bruker's EBITDA registered a high of $131.0 million during Q4 2022, and its lowest value of -$51.8 million during Q3 2025.
  • Its 5-year average for EBITDA is $56.2 million, with a median of $58.5 million in 2023.
  • In the last 5 years, Bruker's EBITDA skyrocketed by 22755.91% in 2021 and then plummeted by 17606.46% in 2025.
  • Over the past 5 years, Bruker's EBITDA (Quarter) stood at $80.6 million in 2021, then soared by 62.53% to $131.0 million in 2022, then fell by 20.99% to $103.5 million in 2023, then tumbled by 30.34% to $72.1 million in 2024, then crashed by 171.84% to -$51.8 million in 2025.
  • Its EBITDA was -$51.8 million in Q3 2025, compared to $11.9 million in Q2 2025 and $31.8 million in Q1 2025.